Table 2.
Assessment of neuropathy: results from the neurological examinations, nerve conduction studies, and composite total neuropathy score.
Mean scores (SD) | Subjects (n = 37) | Population norms |
---|---|---|
Neuropathy impairment score (NIS) | 3.0 (3.6) | 0 |
Nerve conduction studies (NCS) | ||
Peroneal nerve CMAP amplitude (mV) | 3.8 (2.0) | 9.5 (3.7) |
Sural nerve SNAP amplitude (µV) | 16.1 (9.9) | 14.4 (7.0) |
Median nerve CMAP amplitude (mV)* | 10.1 (3.6) | 13.2 (4.1) |
Median nerve SNAP amplitude (µV)† | 36.8 (18.4) | 25.7 (8.9) |
Total neuropathy score reduced (TNSr) | 4.0 (2.0) |
CMAP, compound muscle action potential; SNAP, sensory nerve action potential.
One child refused median nerve CMAP.
Two children refused median nerve SNAP.